menu
    • menu

    Company profile for Emergence Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Emergence Therapeutics is a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. Our lead program features innovative antibody design as well as state of the art linker and payload technology to target Nectin-4 – an important and validated target for a broad range of cancers.. This approach brings the promise of superiority to enfortumab vedotin, ...
    Emergence Therapeutics is a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. Our lead program features innovative antibody design as well as state of the art linker and payload technology to target Nectin-4 – an important and validated target for a broad range of cancers.. This approach brings the promise of superiority to enfortumab vedotin, a high-profile ADC for urothelial cancer which received US FDA accelerated approval in December 2019. Emergence is led by a strong management team supported by a network of world-leading experts in immuno-oncology

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Emergence TherapeuticsGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Schifferstrasse 210 47059 Duisburg
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://emergencetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/emergence-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lilly quietly completes purchase of Padcev competitor, estimated at half a B USD
    Lilly quietly completes purchase of Padcev competitor, estimated at half a B USD

    30 Aug 2023

    // Lei Lei Wu ENDPTS

    https://endpts.com/lilly-quietly-completes-purchase-of-padcev-competitor-estimated-at-nearly-half-a-billion-dollars/

    Lei Lei Wu ENDPTS
    30 Aug 2023
    Share Share
    Synaffix allies with Emergence in $360M biobuck ADC pact
    Synaffix allies with Emergence in $360M biobuck ADC pact

    07 Sep 2022

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/synaffix-rustles-another-adc-deal-allying-emergence-360m-biobuck-pact

    Nick Paul Taylor FIERCEBIOTECH
    07 Sep 2022
    Share Share
    Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal
    Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal

    06 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/emergence-therapeutics-licenses-synaffix-adc-technology-platform-in-360m-deal-301617866.html

    PRNEWSWIRE
    06 Sep 2022
    Share Share
    Emergence strengthens leadership team with the appointment of Hatem Azim as CMO
    Emergence strengthens leadership team with the appointment of Hatem Azim as CMO

    07 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/07/2457286/0/en/Emergence-Therapeutics-strengthens-leadership-team-with-the-appointment-of-Hatem-Azim-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    07 Jun 2022
    Share Share
    Emergence Therapeutics Closes €87 Million Series A Financing Round
    Emergence Therapeutics Closes €87 Million Series A Financing Round

    07 Dec 2021

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2021-12-07/emergence-therapeutics-closes-87-million-series-a-financing-round/?widget=listSection

    CONTRACTPHARMA
    07 Dec 2021
    Share Share
    Emergence Therapeutics raises €87 mSeries A financing to advance Nectin-4 ADC
    Emergence Therapeutics raises €87 mSeries A financing to advance Nectin-4 ADC

    07 Dec 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/12/07/2347245/0/en/Emergence-Therapeutics-raises-87-million-Series-A-financing-to-advance-Nectin-4-ADC.html

    GLOBENEWSWIRE
    07 Dec 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search